Search

Your search keyword '"Croft, Nick"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Croft, Nick" Remove constraint Author: "Croft, Nick" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
49 results on '"Croft, Nick"'

Search Results

1. References

3. Governance

4. Front Matter

9. Preface

10. Index

13. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

14. Planning Education: Exchanging Approaches to Teaching Practice-Based Skills

17. Preface

19. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

20. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline From the European Crohnʼs and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition

21. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline From European Crohnʼs and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition

22. Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response

29. Implementing Digital Image Correlation for Determining the Tensile Characteristics of Post-Processed Thin Sheet Metal

30. Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel

31. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease

32. Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel.

33. Management of paediatric ulcerative colitis, Part 1: ambulatory care- an evidence-based guideline from ECCO and ESPGHAN

34. Management of paediatric ulcerative colitis, Part 2: acute severe colitis; an evidence-based consensus guideline from ECCO and ESPGHAN

35. Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients

37. Computational Fluid Dynamics and Visualisation of Coastal Flows in Tidal Channels Supporting Ocean Energy Development

44. Towards cost effective and sustainable renewable energy storage batteries

45. Fluidic nozzles for automotive washer systems : computational fluid dynamics and experimental analysis

47. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition

48. Management of paediatric ulcerative colitis, part 2: Acute severe colitis - An evidence-based consensus guideline from the european Crohn's and colitis organization and the european society of paediatric gastroenterology, hepatology and nutrition

49. Emerging patterns of inflammatory bowel disease in sub-Saharan Africa: 175 cases from an IBD network.

Catalog

Books, media, physical & digital resources